Trainings By Informa Markets
Informa


Risk Assessment: A Unique Strategy to Avoid Nitrosamines

Duration - 76 Minutes

About the course

Practical Approaches to risk assessments
  • How to conduct a risk assessment and to identify key factors
  • Applicability to use ICH M7 based cancer risk assessment to the cohort of concern
  • Assessment and communication of risks considering expectations by regulatory authorities

Speaker Profile

Dr. Venkat Manohar

Director
Indian Institute of Chromatography & Mass Spectrometry (IICMS)

Dr. Aloka Srinivasan

Principal - RAAHA LLC.
Former USFDA

Dr. Andrew Teasdale

Senior Principal Scientist Impurity management and External Advocacy
AstraZeneca

Dr. George Johnson

Professor
Swansea University

Dr. Joel Bercu

Senior Director
Gilead Sciences




Website by: Xpoteck